Related Experiment Video
Updated: Mar 25, 2026

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
Insulin action, thermogenesis and obesity
1Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Obesity causes insulin resistance, but insulin resistance does not appear to cause obesity by lowering metabolic rate. Meal-induced thermogenesis may impact satiety and energy balance, though research is limited.
Area of Science:
- Metabolic research
- Obesity studies
- Endocrinology
Background:
- Obesity is strongly linked to insulin resistance.
- Lipid oversupply in obesity negatively impacts insulin's control of glucose metabolism.
Purpose of the Study:
- To investigate if insulin resistance, a common feature of obesity, contributes to obesity by reducing thermogenesis.
- To explore the complex relationship between insulin resistance and energy expenditure in obese individuals.
Main Methods:
- Population-based comparison of metabolic rates between lean and obese individuals.
- Analysis of thermogenesis in relation to insulin action and weight loss.
- Examination of meal-induced and glucose-induced thermogenesis.
Main Results:
- Obese individuals do not generally exhibit lower metabolic rates than lean individuals.
- No convincing evidence links reduced metabolic rate in hypometabolic obese individuals to severe insulin resistance.
- Weight loss and improved insulin action do not significantly increase thermogenesis.
Conclusions:
- Insulin resistance is unlikely to cause obesity through reduced overall thermogenesis.
- A potential role for impaired prandial thermogenesis in affecting satiety and energy intake exists but requires further research.
- The primary drivers of obesity remain multifactorial, with insulin resistance not appearing to be a direct cause via metabolic rate reduction.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin Secretory Vesicles

